In 2017, Cochrane conducted a literature review of relevant studies, and found some positive evidence for preoperative use of GnRH analogues to shrink uterine fibroids, a kind of tumour, before surgical treatment. https://t.co/hcGdZmOnbk
Important update with inclusion of preoperative pharmacological treatment: https://t.co/15b1w32X84 @CochraneUK https://t.co/f0GFtkjt5I
RT @CochraneLibrary: #CochraneEvidence: preoperative gonadotropin-hormone releasing analogues (GnRHa) reduce uterine and #fibroid volume, a…
#CochraneEvidence: preoperative gonadotropin-hormone releasing analogues (GnRHa) reduce uterine and #fibroid volume, and increase preoperative #haemoglobin levels, although GnRHa also increases incidence of hot flushes: https://t.co/PebfuEQNqh
RT @CochraneUK: #CochraneEvidence: preoperative gonadotropin-hormone releasing analogues (GnRHa) reduce uterine and #fibroid volume, and in…
Preoperative medical therapy before surgery for uterine fibroids https://t.co/KpL4GUk67J
Read the latest #Cochrane review on preoperative medical therapy before surgery for #uterine #fibroids: https://t.co/2RmID87Chk https://t.co/oPGbTfsK8h
Updated #Cochrane evidence available on preoperative medical therapy before surgery for uterine fibroids: https://t.co/x4qF6vo9E4